Disease | ovarian cancer |
Phenotype | C0016629|fowlpox |
Sentences | 1 |
PubMedID- 26158218 | Treatment of advanced melanoma and ovarian cancer patients with a recombinant fowlpox-ny-eso-1 vaccine resulted in ny-eso-1 antibody and cd4+ and cd8+ t-cell responses in the majority of these patients, and cd8+ responses correlated with progression-free survival [91, 92]. |
Page: 1